Conducting Clinical Trials in the US and Abroad: Navigating the Rising Tide of Regulation and Risk

    October 2009

    The regulatory landscape for clinical trials, both in the United States and globally, has become increasingly complex.

    In this white paper, Maureen Bennett, partner and chair of Squire Sanders’ Global Life Science Practice and Jan Murray, Deputy Chief Legal Officer, Cleveland Clinic, discuss several areas surrounding this topic including strategies for minimizing risk, special considerations in conducting clinical trials in developing regions, the relationship between the life sciences industry and academia, and more.

    Read the full white paper on Conducting Clinical Trials in the US and Abroad: Navigating the Rising Tide of Regulation and Risk.